Fig. 9

(A) Role of biomarkers in cancer-related pathways Red is activation, green is inhibition and grey is no effect. (B) Biomarker-disease co-expression network. (C) Biomarker-drug interaction networks. Results of molecular docking simulations of biomarkers. (D) LNX1-Pyrophosphoric acid. (E) KAT2B-Cocaine. (F) KAT2B-Dextroamphetamine